Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cortico-basal degeneration]

M Morimatsu1

  • 1Department of Neurology, Yamaguchi University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Corticobasal degeneration (CBD) is more common than previously thought. Definitive diagnosis requires molecular biology to differentiate it from other neurodegenerative diseases like Alzheimer's.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of leiomyomatosis peritonealis disseminata treated with a gn-rh analog.

Oncology reports·2011
Same author

In-vitro cytotoxicity in ovarian-cancer of low-dose continuous exposure to microtubule inhibitors (Paclitaxel taxotere) combined with Cisplatin.

Oncology reports·2011
Same author

Metastases observed autopsy in 70 women with ovarian-cancer - relationship to treatment.

Oncology reports·2011
Same author

Neural cell adhesion molecule expression in thyroid cancer.

Oncology reports·2011
Same author

A role of matrix metalloproteinases produced by glioma-cells.

International journal of oncology·2011
Same author

Treatment for superficial esophageal cancer based on histological features and gross appearance.

International journal of oncology·2011

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Context:

  • Corticobasal degeneration (CBD) is a rare neurodegenerative disorder.
  • The study observed 13 CBD patients over 8 years, with a 1:18 ratio to Parkinson's disease patients.
  • Clinical diagnosis relies on specific motor and cognitive signs, often asymmetric, and neuroimaging findings.

Purpose:

  • To highlight the prevalence of Corticobasal degeneration (CBD).
  • To define clinical criteria for diagnosing CBD.
  • To emphasize the need for advanced molecular investigations for accurate diagnosis.

Summary:

  • Established clinical criteria for Corticobasal degeneration (CBD) include limb-kinetic apraxia, akinetic-rigid signs, marked asymmetry, and supportive neuroimaging.
  • Additional findings like alien hand sign and reflex myoclonus aid in diagnosis.

Related Experiment Videos

  • Pathological misdiagnosis of CBD as Pick's disease, progressive supranuclear palsy, or Alzheimer's disease necessitates further research.

    • Impact:

    • Suggests CBD may be underdiagnosed.
    • Provides a framework for clinical identification of CBD.
    • Underscores the importance of molecular biology in distinguishing CBD from other complex neurodegenerative disorders.